Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3 studies found for:    "Hyperlipoproteinemia type 3"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Unknown  DARK STUDY "DysbetalipoproteinemiA and atheRoma Risk"
Condition: Dysbetalipoproteinemia
2 Completed Type III Dysbetalipoproteinemia
Condition: Hyperlipoproteinemia Type III
Interventions: Drug: Rosuvastatin;   Drug: rosuvastatin;   Drug: pravastatin
3 Terminated Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.
Condition: Hyperlipoproteinemia Type III
Interventions: Drug: torcetrapib/atorvastatin;   Drug: atorvastatin;   Drug: fenofibrate

Study has passed its completion date and status has not been verified in more than two years.